IP Library › Assignment 064118/0112
Patent Assignment
Reel/Frame 064118/0112

Assignment of Assignor's Interest

Recorded: 2023-06-29 Pages: 7
Assignor
CLEAVE THERAPEUTICS, INC.
Executed: 2023-05-17
Assignee
EIKON THERAPEUTICS, INC.
3929 POINT EDEN WAY, HAYWARD, CALIFORNIA, 94545
Covered Property (1)
Fused Pyrimidines as Inhibitors of P97 Complex
Patent: 9,475,824 →
Application: 14/416,033 →
Publication: US 2015/0239907
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2015
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO; WUSTROW, DAVID
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 034789/0921 →
Change of Name Jul 24, 2023
From: CLEAVE BIOSCIENCES, INC.
To: CLEAVE THERAPEUTICS, INC.
Reel/Frame 064357/0601 →